Georgia Capital Shareholder and Market Opportunity Overview
Private large
portfolio companies
EXTERNALLY VALUED
A RETAIL (PHARMACY) BUSINESS OVERVIEW
ӨӨ
Country's largest retailer in terms of both, revenue and number of bills issued
BUSINESSES MAJOR GROWTH DRIVERS
GHG in pharma
PSP
Market share by revenue,
20181
Aversi
305
Other
338
519
32%
460
28%
19%
21%
>
Expending retail footprint
> Enhancing retail margin (private label products)
> New retail categories such as lab service and beauty
GEORGIA
CAPITAL
>
Growing wholesale revenue (such as hospital supplies)
>
Digital channels
Medium to long-term targets
☐
Double digit revenue CAGR
Π
9%+ EBITDA margin
318
Operates under two pharmacy brands, each with a distinct positioning:
> GPC for the high-end customer segment
>
Pharmadepot for the mass retail segment
318
Pharmacies countrywide
216
120
128
60
32
23
38
96
102
68
37
9
Shopping Areas
Clinic
24
Residential area
High street
Total
GPC
Pharmadepot
Georgia Capital PLC | 1. Total market size 2018 - Frost & Sullivan analysis, revenue distribution between competitors represents managements estimates.
48View entire presentation